Literature DB >> 7053656

Cholecystectomy in cirrhotic patients: a formidable operation.

G V Aranha, S J Sontag, H B Greenlee.   

Abstract

Cholecystectomy and common bile duct exploration in cirrhotic patients is associated with an 83 percent mortality if prothrombin time is prolonged 2.5 seconds over control. The causes of death are related to complications of liver disease such as hepatic encephalopathy, ascites, sepsis and hemorrhage. If the prothrombin time is prolonged, major intraoperative blood loss can be anticipated, and blood and plasma transfusion requirements may be massive. Jaundice in the presence of cirrhosis requires careful preoperative evaluation and is most frequently due to hepatocellular disease rather than extrahepatic biliary obstruction. Cholecystectomy and common duct exploration in cirrhotic patients should be performed only for life-threatening complications of biliary tract disease such as empyema, perforation and ascending cholangitis.

Entities:  

Mesh:

Year:  1982        PMID: 7053656     DOI: 10.1016/0002-9610(82)90129-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  56 in total

1.  Recent results of elective open cholecystectomy in a North American and a European center. Comparison of complications and risk factors.

Authors:  P A Clavien; J R Sanabria; G Mentha; F Borst; L Buhler; B Roche; R Cywes; R Tibshirani; A Rohner; S M Strasberg
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

2.  Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation.

Authors:  Roshan Shrestha; David M S Grunkemeier
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

3.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  Surgery for gastric cancer in patients with cirrhosis.

Authors:  H Isozaki; K Okajima; T Ichinona; K Fujii; E Nomura; N Izumi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery.

Authors:  Chandra Kant Pandey; Sunaina Tejpal Karna; Vijay Kant Pandey; Manish Tandon; Amit Singhal; Vivek Mangla
Journal:  World J Gastrointest Surg       Date:  2012-12-27

6.  Deaths from gallstones. Incidence and associated clinical factors.

Authors:  G Cucchiaro; C R Watters; J C Rossitch; W C Meyers
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

7.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

8.  Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy?

Authors:  M Sugiyama; Y Atomi; A Kuroda; T Muto
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

9.  Laparoscopic cholecystectomy in cirrhotic patients: feasibility in a developing country.

Authors:  Mohammad Tayeb; Muhammad R Khan; Nazia Riaz
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

Review 10.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.